Prevalence and characteristics of adverse drug events in Brazil

Detalhes bibliográficos
Autor(a) principal: Livia Alves Oliveira de Sousa
Data de Publicação: 2018
Outros Autores: Marta Maria de França Fonteles, Mirian Parente Monteiro, Sotero Serrate Mengue, Andréa Dâmaso Bertoldi, Tatiane da Silva Dal Pizzol, Noemia Urruth Leão Tavares, Maria Auxiliadora Oliveira, Vera Lucia Luiza, Luiz Roberto Ramos, Mareni Rocha Farias, Paulo Sergio Dourado Arrais
Tipo de documento: Artigo
Idioma: eng
por
Título da fonte: Cadernos de Saúde Pública
Texto Completo: https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759
Resumo: The aim of this study was to describe the prevalence of adverse drug events (ADEs) and associated factors reported by users of medicines in Brazil. This was a cross-sectional population-based study conducted from September 2013 to February 2014 with data from the Brazilian National Survey on Access, Use, and Promotion of Rational Use of Medicines (PNAUM). The study included all individuals that reported the use of medicines and identified, among them, all those reporting at least one problem with the medicine’s use. A descriptive analysis was performed to estimate ADE prevalence and 95% confidence intervals (95%CI) among the target variables. Crude and adjusted prevalence ratios were calculated using Poisson regression to investigate factors associated with ADEs. Overall ADE prevalence in Brazil was 6.6% (95%CI: 5.89-7.41), and after multivariate analysis, higher prevalence was associated with female gender, residence in the Central and Northeast regions, consumption of more medicines, “bad” self-rated health, and self-medication. The drugs most frequently reported with ADEs were fluoxetine, diclofenac, and amitriptyline. The most frequent ADEs were somnolence, epigastric pain, and nausea. Most reported ADEs were mild, avoidable, and associated with medicines used frequently by the population. The study provided knowledge on the size of the problem with use of medicines in Brazil.
id FIOCRUZ-5_a536c6a99ed07d6f67ad6350800c1cb4
oai_identifier_str oai:ojs.teste-cadernos.ensp.fiocruz.br:article/6759
network_acronym_str FIOCRUZ-5
network_name_str Cadernos de Saúde Pública
repository_id_str
spelling Prevalence and characteristics of adverse drug events in BrazilPrevalência e características dos eventos adversos a medicamentos no BrasilDrug UtilizationDrug-Related Side Effects and Adverse ReactionsPharmacovigilanceHealth SurveysUso de MedicamentosEfeitos Colaterais e Reações Adversas Relacionados a MedicamentosFarmacovigilânciaInquéritos EpidemiológicosThe aim of this study was to describe the prevalence of adverse drug events (ADEs) and associated factors reported by users of medicines in Brazil. This was a cross-sectional population-based study conducted from September 2013 to February 2014 with data from the Brazilian National Survey on Access, Use, and Promotion of Rational Use of Medicines (PNAUM). The study included all individuals that reported the use of medicines and identified, among them, all those reporting at least one problem with the medicine’s use. A descriptive analysis was performed to estimate ADE prevalence and 95% confidence intervals (95%CI) among the target variables. Crude and adjusted prevalence ratios were calculated using Poisson regression to investigate factors associated with ADEs. Overall ADE prevalence in Brazil was 6.6% (95%CI: 5.89-7.41), and after multivariate analysis, higher prevalence was associated with female gender, residence in the Central and Northeast regions, consumption of more medicines, “bad” self-rated health, and self-medication. The drugs most frequently reported with ADEs were fluoxetine, diclofenac, and amitriptyline. The most frequent ADEs were somnolence, epigastric pain, and nausea. Most reported ADEs were mild, avoidable, and associated with medicines used frequently by the population. The study provided knowledge on the size of the problem with use of medicines in Brazil.El presente trabajo tiene como objetivo describir la prevalencia y factores asociados a eventos adversos con medicamentos (EAM), informados por usuarios de medicamentos en Brasil. Se trata de un estudio transversal de base poblacional, realizado durante el período de septiembre de 2013 a febrero de 2014, con datos recogidos en la Encuesta Nacional sobre el Acceso, Utilización y Promoción del Uso Racional de Medicamentos en Brasil (PNAUM). Se consideraron a todas las personas que informaron del uso de medicamentos; entre ellas, se identificaron a las que informaron de por lo menos un problema con el uso del medicamento. Se realizó un análisis descriptivo para estimar la prevalencia y los intervalos de confianza a 95% (IC95%) de EAM entre las variables estudiadas, y se calcularon las razones de prevalencia bruta y ajustada, por la regresión de Poisson, en la investigación de los factores asociados a los EAM. La prevalencia de EAM en Brasil fue de un 6,6% (IC95%: 5,89-7,41), siendo mayor y estadísticamente significante tras la realización del análisis multivariado, entre personas del sexo femenino; residentes en las regiones Centro-Oeste y Nordeste; que consumían un mayor número de medicamentos; que percibían su estado de salud como “malo”; y que se automedicaban. Se informaron de más EAM en medicamentos como: fluoxetina, diclofenaco y amitriptilina. Los EAM más referidos por los entrevistados fueron somnolencia, dolor epigástrico y náuseas. Los EAM más referidos por los entrevistados fueron de naturaleza leve, considerados evitables y estuvieron asociados a medicamentos de uso frecuente por la población. Con motivo de este estudio, fue posible conocer la dimensión del problema ocasionado por el uso de medicamentos en Brasil.O presente trabalho tem como objetivo descrever a prevalência e fatores associados a eventos adversos a medicamentos (EAM) referidos por usuários de medicamentos no Brasil. Trata-se de um estudo transversal de base populacional, realizado no período de setembro de 2013 a fevereiro de 2014, com dados coletados na Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM). Foram consideradas todas as pessoas que referiram o uso de medicamentos; entre elas, foram identificadas as que referiram pelo menos um problema com o uso do medicamento. Realizou-se uma análise descritiva para estimar a prevalência e os intervalos de 95% de confiança (IC95%) de EAM entre as variáveis estudadas, e foram calculadas as razões de prevalência bruta e ajustada, pela regressão de Poisson, na investigação dos fatores associados aos EAM. A prevalência de EAM no Brasil foi de 6,6% (IC95%: 5,89-7,41), sendo maior e estatisticamente significante após a realização da análise multivariada, entre pessoas do sexo feminino; residentes nas regiões Centro-oeste e Nordeste; que consumiam maior número de medicamentos; que percebiam seu estado de saúde como “ruim”; e que se automedicavam. Os EAM foram mais relatados para os medicamentos fluoxetina, diclofenaco e amitriptilina. Os EAM mais referidos pelos entrevistados foram sonolência, dor epigástrica e náuseas. Os EAM mais referidos pelos entrevistados foram de natureza leve, considerados evitáveis e estiveram associados a medicamentos de uso frequente pela população. Em razão desse estudo, foi possível conhecer a dimensão do problema ocasionado pelo uso de medicamentos no Brasil.Reports in Public HealthCadernos de Saúde Pública2018-03-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmltext/htmlapplication/pdfapplication/pdfhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759Reports in Public Health; Vol. 34 No. 4 (2018): AprilCadernos de Saúde Pública; v. 34 n. 4 (2018): Abril1678-44640102-311Xreponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZengporhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14586https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14587https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14588https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14589Livia Alves Oliveira de SousaMarta Maria de França FontelesMirian Parente MonteiroSotero Serrate MengueAndréa Dâmaso BertoldiTatiane da Silva Dal PizzolNoemia Urruth Leão TavaresMaria Auxiliadora OliveiraVera Lucia LuizaLuiz Roberto RamosMareni Rocha FariasPaulo Sergio Dourado Arraisinfo:eu-repo/semantics/openAccess2024-03-06T15:29:31Zoai:ojs.teste-cadernos.ensp.fiocruz.br:article/6759Revistahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csphttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/oaicadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2024-03-06T13:07:43.822293Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)true
dc.title.none.fl_str_mv Prevalence and characteristics of adverse drug events in Brazil
Prevalência e características dos eventos adversos a medicamentos no Brasil
title Prevalence and characteristics of adverse drug events in Brazil
spellingShingle Prevalence and characteristics of adverse drug events in Brazil
Livia Alves Oliveira de Sousa
Drug Utilization
Drug-Related Side Effects and Adverse Reactions
Pharmacovigilance
Health Surveys
Uso de Medicamentos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos
Farmacovigilância
Inquéritos Epidemiológicos
title_short Prevalence and characteristics of adverse drug events in Brazil
title_full Prevalence and characteristics of adverse drug events in Brazil
title_fullStr Prevalence and characteristics of adverse drug events in Brazil
title_full_unstemmed Prevalence and characteristics of adverse drug events in Brazil
title_sort Prevalence and characteristics of adverse drug events in Brazil
author Livia Alves Oliveira de Sousa
author_facet Livia Alves Oliveira de Sousa
Marta Maria de França Fonteles
Mirian Parente Monteiro
Sotero Serrate Mengue
Andréa Dâmaso Bertoldi
Tatiane da Silva Dal Pizzol
Noemia Urruth Leão Tavares
Maria Auxiliadora Oliveira
Vera Lucia Luiza
Luiz Roberto Ramos
Mareni Rocha Farias
Paulo Sergio Dourado Arrais
author_role author
author2 Marta Maria de França Fonteles
Mirian Parente Monteiro
Sotero Serrate Mengue
Andréa Dâmaso Bertoldi
Tatiane da Silva Dal Pizzol
Noemia Urruth Leão Tavares
Maria Auxiliadora Oliveira
Vera Lucia Luiza
Luiz Roberto Ramos
Mareni Rocha Farias
Paulo Sergio Dourado Arrais
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Livia Alves Oliveira de Sousa
Marta Maria de França Fonteles
Mirian Parente Monteiro
Sotero Serrate Mengue
Andréa Dâmaso Bertoldi
Tatiane da Silva Dal Pizzol
Noemia Urruth Leão Tavares
Maria Auxiliadora Oliveira
Vera Lucia Luiza
Luiz Roberto Ramos
Mareni Rocha Farias
Paulo Sergio Dourado Arrais
dc.subject.por.fl_str_mv Drug Utilization
Drug-Related Side Effects and Adverse Reactions
Pharmacovigilance
Health Surveys
Uso de Medicamentos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos
Farmacovigilância
Inquéritos Epidemiológicos
topic Drug Utilization
Drug-Related Side Effects and Adverse Reactions
Pharmacovigilance
Health Surveys
Uso de Medicamentos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos
Farmacovigilância
Inquéritos Epidemiológicos
description The aim of this study was to describe the prevalence of adverse drug events (ADEs) and associated factors reported by users of medicines in Brazil. This was a cross-sectional population-based study conducted from September 2013 to February 2014 with data from the Brazilian National Survey on Access, Use, and Promotion of Rational Use of Medicines (PNAUM). The study included all individuals that reported the use of medicines and identified, among them, all those reporting at least one problem with the medicine’s use. A descriptive analysis was performed to estimate ADE prevalence and 95% confidence intervals (95%CI) among the target variables. Crude and adjusted prevalence ratios were calculated using Poisson regression to investigate factors associated with ADEs. Overall ADE prevalence in Brazil was 6.6% (95%CI: 5.89-7.41), and after multivariate analysis, higher prevalence was associated with female gender, residence in the Central and Northeast regions, consumption of more medicines, “bad” self-rated health, and self-medication. The drugs most frequently reported with ADEs were fluoxetine, diclofenac, and amitriptyline. The most frequent ADEs were somnolence, epigastric pain, and nausea. Most reported ADEs were mild, avoidable, and associated with medicines used frequently by the population. The study provided knowledge on the size of the problem with use of medicines in Brazil.
publishDate 2018
dc.date.none.fl_str_mv 2018-03-29
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759
url https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759
dc.language.iso.fl_str_mv eng
por
language eng
por
dc.relation.none.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14586
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14587
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14588
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14589
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
text/html
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
dc.source.none.fl_str_mv Reports in Public Health; Vol. 34 No. 4 (2018): April
Cadernos de Saúde Pública; v. 34 n. 4 (2018): Abril
1678-4464
0102-311X
reponame:Cadernos de Saúde Pública
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Cadernos de Saúde Pública
collection Cadernos de Saúde Pública
repository.name.fl_str_mv Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br
_version_ 1798943386702446592